Buy Boston Scientific: Down But Not Out

Owing to the slowdown in the broader cardiology market, and specifically in the drug-eluting stent and implantable cardiovascular defibrillator market, revenues for Boston Scientific have come under increasing pressure.
Seeking Alpha